Department: Clinical Cooperation Unit Pediatric Oncology
Code number: 2023-0137
The German Cancer Research Center is the largest biomedical research institution in Germany. With more than 3,000 employees, we operate an extensive scientific program in the field of cancer research.
Within the Translational Program of KiTZ (https: // www. kitz- heidelberg.de/en/), we are setting up a new PreTrial Unit (Preclinical tRial developmEnt uniT foR pedIAtric oncoLogy). The aim of this unique translational unit is to generate preclinical data packages to support early phase clinical trial development in pediatric oncology based on innovative mechanism of action-based discoveries made by KiTZ groups and cooperation partners.
The scientist will be responsible for clinically focused automated high- throughput drug screening with molecularly fully characterized cell models and zebrafish PDX models. The position will directly supervise a technician and be responsible for data analysis, biomarker validation, reporting and contribution to publication of results.
The PreTrial Unit will be located within the Clinical Cooperation Unit Pediatric Oncology at DKFZ and is closely interacting with other groups of the KiTZ, DKFZ and University Hospital. The unit is supported by a large translational research grant (KiTZ CTU 2.0) from the Dietmar Hopp Foundation.
Applicants should hold a PhD in biology or related fields with strong interests in translational cancer research and considerable postdoctoral experience with outstanding expertise in cell biology, including all relevant assays required for preclinical in vitro and in vivo drug development. We expect a scientist capable of working independently with experience in supervision of technical personnel. Very good communication skills and team player capabilities are key, as there will be close interactions with other researchers, project managers, technicians, the pharma industry and the KiTZ translational advisory board.
The DKFZ is subject to the regulations of the Infection Protection Act (IfSG). As a consequence, only persons who present proof of immunity against measles may work at the DKFZ.
Earliest Possible Start Date: as soon as possible
Duration: The position is initially limited to 2 years with the possibility of prolongation.
The position can in principle be part-time.
Application Deadline: 26.05.2023
Dr. Ina Oehme Phone +49 (0)6221/42-3388
Please note that we do not accept applications submitted via email.
The DKFZ is committed to increase the proportion of women in all areas and positions in which women are underrepresented. Qualified female applicants are therefore particularly encouraged to apply.
Among candidates of equal aptitude and qualifications, a person with disabilities will be given preference.
To apply for a position please use our online application portal (https: // www. dkfz.de/en/stellenangebote/index.php).
We ask for your understanding that we cannot return application documents that are sent to us by post (Deutsches Krebsforschungszentrum, Personalabteilung, Im Neuenheimer Feld 280, 69120 Heidelberg) and that we do not accept applications submitted via email. We apologize for any inconvenience this may cause.